1208319-27-0 (奥拉替尼马来酸盐,Oclacitinib maleate)

N-甲基-1-(反式-4-(甲基(7H-吡咯并[2,3-d]嘧啶-4-基)氨基)环己基)甲磺酰胺x马来酸盐;

PF 03394197-11;Oclacitinib (maleate);OCLACITINIB MALEATE;Oclacitinib maleate [USAN];VON733L42A;Oclacitinib maleate (USAN);AMY19492;s8195;D10142;Q27291934;Cyclohexanemethanesulfonamide, N-methyl-4-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4- ylamino)-, trans-, (2Z)-2-butenedioate (1:?);N-Methyl(trans-4-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-y;N-methyl-1-(trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide maleate(1:x);1208319-27-0;HY-13577A;N-Methyl(trans-4-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)cyclohexyl) methanesulfonamide (2Z)-2-butenedioate;OCLACITINIB MALEATE (EMA EPAR: VETERINARY);Oclacitinib maleate?;EX-A3658;N-Methyl[trans-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexyl] methanesulfonamide (2Z)-2-butenedioate;GLXC-15415;UNII-VON733L42A;PF-03394197-11;PF-03394197 maleate;SCHEMBL260868;CCG-269269;1640292-55-2;(Z)-but-2-enedioic acid;N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide;CHEMBL2105739;CS-7611;AC-32980;N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide maleate;Apoquel;D84061;BS-44681;Oclacitinib(maleate);SCHEMBL19205843;OCLACITINIB MALEATE [MI];Oclacitinib Maleate(PF-03394197);AKOS040759049;

VQIGDTLRBSNOBV-BTJKTKAUSA-N

1S/C15H23N5O2S.C4H4O4/c1-16-23(21,22)9-11-3-5-12(6-4-11)20(2)15-13-7-8-17-14(13)18-10-19-15;5-3(6)1-2-4(7)8/h7-8,10-12,16H,3-6,9H2,1-2H3,(H,17,18,19);1-2H,(H,5,6)(H,7,8)/b;2-1-

S(CC1CCC(CC1)N(C)C1C2C=CNC=2N=CN=1)(NC)(=O)=O.OC(/C=C\C(=O)O)=O